SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-24-037430
Filing Date
2024-03-22
Accepted
2024-03-21 19:38:44
Documents
7
Period of Report
2024-03-21

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm247743d7_6k.htm 6-K 208158
2 GRAPHIC tm247743d7_6kimg001.jpg GRAPHIC 17123
3 GRAPHIC tm247743d7_6kimg002.jpg GRAPHIC 14577
4 GRAPHIC tm247743d7_6kimg003.jpg GRAPHIC 34737
5 GRAPHIC tm247743d7_6kimg005.jpg GRAPHIC 7093
6 GRAPHIC tm247743d7_6kimg007.jpg GRAPHIC 2427
7 GRAPHIC tm247743d7_6kimg01.jpg GRAPHIC 10457
  Complete submission text file 0001104659-24-037430.txt   329096
Mailing Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036
Business Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036 212-969-3335
Grifols SA (Filer) CIK: 0001438569 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35193 | Film No.: 24772755
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)